Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,055 JPY | -0.49% | +3.14% | +20.28% |
Apr. 15 | AstraZeneca: expects a sharp rise in kidney disease | CF |
Apr. 11 | TVS Supply Chain's Supply of CKD Kits to TVS Motor Crosses 500,000 | MT |
Sales 2024 | 134B 863M | Sales 2025 * | 148B 952M | Capitalization | 204B 1.31B |
---|---|---|---|---|---|
Net income 2024 | 8.34B 53.51M | Net income 2025 * | 11.96B 76.78M | EV / Sales 2024 | 1.5 x |
Net Debt 2024 * | 10.09B 64.78M | Net Debt 2025 * | 4.54B 29.11M | EV / Sales 2025 * | 1.41 x |
P/E ratio 2024 |
24.1
x | P/E ratio 2025 * |
17
x | Employees | 4,684 |
Yield 2024 |
1.66% | Yield 2025 * |
2.39% | Free-Float | 82.37% |
1 day | -0.49% | ||
1 week | +3.14% | ||
Current month | +2.21% | ||
1 month | -3.63% | ||
3 months | +29.23% | ||
6 months | +54.06% | ||
Current year | +20.28% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 67 | 80-03-31 | |
Katsuhito Okuoka
PSD | President | 56 | 91-03-31 |
Director/Board Member | 63 | 84-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 67 | 80-03-31 | |
Shinji Yuhara
BRD | Director/Board Member | 61 | 86-03-31 |
Stefan Sacré
BRD | Director/Board Member | 61 | 21-06-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.37% | 0 M€ | +24.17% | ||
0.03% | 0 M€ | +17.26% | ||
0.02% | 0 M€ | +15.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 3,055 | -0.49% | 429,400 |
24-05-09 | 3,070 | +0.82% | 184,500 |
24-05-08 | 3,045 | +0.16% | 213,400 |
24-05-07 | 3,040 | +2.63% | 223,000 |
24-05-02 | 2,962 | -0.17% | 209,500 |
Delayed Quote Japan Exchange, May 10, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.28% | 1.31B | |
+5.58% | 15.95B | |
+38.46% | 5.46B | |
-7.43% | 4.79B | |
-14.02% | 4.74B | |
-7.49% | 4.62B | |
+16.99% | 4.45B | |
+14.54% | 3.85B | |
+43.64% | 3.85B | |
-2.99% | 3.19B |
- Stock Market
- Equities
- 6407 Stock